Skip to main content
Have a personal or library account? Click to login
Invasive Candida Infections in the ICU: Diagnosis and Therapy Cover

Invasive Candida Infections in the ICU: Diagnosis and Therapy

The Journal of Critical Care Medicine
Volume 1 (2015): Issue 4 (October 2015)
By: ,  ,   and    
Open Access
|Nov 2015
References

References

  1. 1. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36:1-53.
    Open DOISearch in Google Scholar
  2. 2. Lepak A, Andes D. Fungal sepsis: optimizing antifungal therapy in the critical care setting. Crit Care Clin. 2011;27:123-47.
    Open DOISearch in Google Scholar
  3. 3. Ullmann AJ, Cornely OA, Donnelly JP, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect. 2012;Suppl 7:1-77.
    Open DOISearch in Google Scholar
  4. 4. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-63.
    Open DOISearch in Google Scholar
  5. 5. Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54:1739-46.
    Open DOISearch in Google Scholar
  6. 6. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014;5:161-9.
    Open DOISearch in Google Scholar
  7. 7. Vincent JL, Rello J, Marshall J, et al. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323-9.
    Open DOISearch in Google Scholar
  8. 8. Marchetti O, Bille J, Fluckiger U, et al. Fungal Infection Network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38:311-20.
    Open DOISearch in Google Scholar
  9. 9. Méan M, Marchetti O, Calandra T. Bench to bedside review: Candida infections in the intensive care unit. Crit Care. 2008;12:204.
    Open DOISearch in Google Scholar
  10. 10. Guery BP, Arendrup MC, Auzinger G, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med. 2009;35:55-62.
    Open DOISearch in Google Scholar
  11. 11. Leroy O, Gangneux JP, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med. 2009;37:1612-8.
    Open DOISearch in Google Scholar
  12. 12. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and casecontrol studies. Eur J Clin Microbiol Infect Dis. 2006;25:419-25.
    Open DOISearch in Google Scholar
  13. 13. Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care. 2010;16:445-52.
    Open DOISearch in Google Scholar
  14. 14. Paramythiotou E, Frantzeskaki F, Flevari A, Armaganidis A, Dimopoulos G. Invasive fungal infections in the ICU: how to approach, how to treat. Molecules. 2014;19:1085-119.
    Open DOISearch in Google Scholar
  15. 15. Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1:37.
    Open DOISearch in Google Scholar
  16. 16. León C, Ostrosky-Zeichner L, Schuster M. What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med. 2014;40:808-19.
    Open DOISearch in Google Scholar
  17. 17. León C, Alvarez-Lerma F, Ruiz-Santana S, et al. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis. 2009;28:233-42.
    Open DOISearch in Google Scholar
  18. 18. Magill SS, Swoboda SM, Johnson EA, et al. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn Microbiol Infect Dis. 2006;55:293-301.
    Open DOISearch in Google Scholar
  19. 19. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. AnnSurg. 1994;220:751-8.
    Search in Google Scholar
  20. 20. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-21.
    Open DOISearch in Google Scholar
  21. 21. Scudeller L, Viscoli C, Menichetti F, et al. An Italian consensus for invasive candidiasis management (ITALIC). Infection. 2014;42:263-79.
    Open DOISearch in Google Scholar
  22. 22. Hsu DI, Nguyen M, Nguyen L, Law A, Wong-Beringer A. A multicentre study to evaluate the impact of timing of caspofung in administration on outcomes of invasive candidiasis in nonimmunocompromised adult patients. J Antimicrob Chemother. 2010;65:1765-70.
    Open DOISearch in Google Scholar
  23. 23. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-5.
    Open DOISearch in Google Scholar
  24. 24. Caggiano G, Puntillo F, Coretti C, et al. Candida colonization index in patients admitted to an ICU. Int J Mol Sci. 2011;12:7038-47.
    Open DOISearch in Google Scholar
  25. 25. Posteraro B, De Pascale G, Tumbarello M, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index. Crit Care. 2011;15:R249.
    Open DOISearch in Google Scholar
  26. 26. Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med.2014;40:1429-48.
    Open DOISearch in Google Scholar
  27. 27. Eggimann P, Que YA, Revelly JP, Pagani JL. Preventing invasive candida infections. Where could we do better? J Hosp Infect. 2015;89:302-8.
    Search in Google Scholar
  28. 28. León C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730-7.
    Open DOISearch in Google Scholar
  29. 29. León C, Ruiz-Santana S, Saavedra P, et al. Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37:1624-33.
    Open DOISearch in Google Scholar
  30. 30. Tissot F, Lamoth F, Hauser PM, et al. β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med. 2013;188:1100-9.
    Open DOISearch in Google Scholar
  31. 31. Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol. 2005;43:235-43.
    Open DOISearch in Google Scholar
  32. 32. Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007;26:271-6.
    Open DOISearch in Google Scholar
  33. 33. Ostrosky-Zeichner L, Pappas PG, Shoham S, et al. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses. 2011;54:46-51.
    Open DOISearch in Google Scholar
  34. 34. Reiss E, Morrison CJ. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev. 1993;6:311-23.
    Open DOISearch in Google Scholar
  35. 35. Morris AJ, Byrne TC, Madden JF, Reller LB. Duration of incubation of fungal cultures. J Clin Microbiol. 1996;34:1583-5.
    Open DOISearch in Google Scholar
  36. 36. Obayashi T, Yoshida M, Mori T, et al. Plasma (1-->3)-beta-Dglucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995;345:17-20.
    Open DOISearch in Google Scholar
  37. 37. Ellis M, Al-Ramadi B, Finkelman M, et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol. 2008;57:287-95.
    Open DOISearch in Google Scholar
  38. 38. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654-9.
    Open DOISearch in Google Scholar
  39. 39. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2005;43:5957-62.
    Open DOISearch in Google Scholar
  40. 40. Ostrosky-Zeichner L, Kullberg BJ, Bow EJ, et al. Early treatment of candidemia in adults: a review. Med Mycol. 2011;49:113-20.
    Open DOISearch in Google Scholar
  41. 41. Takesue Y, Kakehashi M, Ohge H, et al. Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg. 2004;28:625-30.
    Open DOISearch in Google Scholar
  42. 42. Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis. 2012;55:521-6.
    Open DOISearch in Google Scholar
  43. 43. Lyons JL, Thakur KT, Lee R, et al. Utility of measuring (1,3)-β-dglucanin cerebrospinal fluid for diagnosis of fungal central nervous system infection. J Clin Microbiol. 2015;53:319-22.
    Open DOISearch in Google Scholar
  44. 44. Ginocchio F, Verrina E, Furfaro E, Cannavò R, Bandettini R, Castagnola E. Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in child receiving continuous peritoneal dialysis. Clin Vaccine Immunol. 2012;19:626-7.
    Open DOISearch in Google Scholar
  45. 45. Mutschlechner W, Risslegger B, Willinger B, et al. Bronchoalveolar Lavage Fluid (1,3) β-D-Glucan for the Diagnosis of Invasive Fungal Infections in Solid Organ Transplantation: A Prospective Multicenter Study. Transplantation. 2015;99:e140-4.
    Open DOISearch in Google Scholar
  46. 46. Schuetz AN. Invasive fungal infections: biomarkers and molecular approaches to diagnosis. Clin Lab Med. 2013;33:505-25.
    Open DOISearch in Google Scholar
  47. 47. Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C, Third European Conference on Infections in Leukemia Group. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14:R222.
    Open DOISearch in Google Scholar
  48. 48. Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther. 2009;7:1201-21.
    Open DOISearch in Google Scholar
  49. 49. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011;49:665-70.
    Open DOISearch in Google Scholar
  50. 50. McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis. 2008;46:890-6.
    Open DOISearch in Google Scholar
  51. 51. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm. 2012;69:1910-4.
    Open DOISearch in Google Scholar
  52. 52. Saracli MA, Fothergill AW, Sutton DA, Wiederhold NP. Detection of triazole resistance among Candida species by matrix-assistedlaser desorption/ionization-time of flight massspectrometry (MALDI-TOF MS). Med Mycol. 2015;53:736-42.
    Open DOISearch in Google Scholar
  53. 53. Skrobik Y, Laverdiere M. Why Candida sepsis should matter to ICU physicians. Crit Care Clin. 2013;29:853-64.
    Open DOISearch in Google Scholar
  54. 54. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-5.
    Open DOISearch in Google Scholar
  55. 55. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis. 2006;43:25-31.
    Open DOISearch in Google Scholar
  56. 56. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002;113:480-5.
    Open DOISearch in Google Scholar
  57. 57. Senn L, Eggimann P, Ksontini R, et al. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med. 2009;35:903-8.
    Open DOISearch in Google Scholar
  58. 58. Bassetti M, Marchetti M, Chakrabarti A, et al. A research agenda on the management of intra-abdominalcandidiasis: results from a consensus of multinational experts. Intensive Care Med. 2013;39:2092-106.
    Open DOISearch in Google Scholar
  59. 59. Maubon D, Garnaud C, Calandra T, Sanglard D, Cornet M. Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med. 2014;40:1241-55.
    Search in Google Scholar
DOI: https://doi.org/10.1515/jccm-2015-0025 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 129 - 139
Submitted on: Jul 2, 2015
Accepted on: Sep 15, 2015
Published online: Nov 10, 2015
Published in print: Oct 1, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Candida,
invasive Candidiasis,
diagnostics,
therapeutic algorihms
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2015 Péter Hankovszky, Domokos Társy, Nándor Öveges, Zsolt Molnár, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 1 (2015): Issue 4 (October 2015)
Previous article
Next article